Blog
RSS FeedPosted by Michael Wonder on 05 Jun 2026
J&J Innovative Medicine Korea wins reimbursement for Darzalex SC regimen in newly diagnosed AL amyloidosis
4 June 2026 - Johnson & Johnson Innovative Medicine Korea said Darzalex subcutaneous injection-based quadruple regimen has received reimbursement in ...
Posted by Michael Wonder on 04 Jun 2026
Pharming announces US FDA acceptance of sNDA resubmission for Joenja (leniolisib) to treat children aged 4 to 11 years with APDS
4 June 2026 - Pharming today announced that the US FDA has accepted its resubmitted supplemental new drug application seeking approval ...
Posted by Michael Wonder on 04 Jun 2026
Biogen’s salanersen receives FDA breakthrough therapy designation for spinal muscular atrophy
4 June 2026 - Biogen announced today that the US FDA has granted salanersen breakthrough therapy designation for the treatment ...
Posted by Michael Wonder on 04 Jun 2026
Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis in adults
3 June 2026 - The MHRA has today authorised the medicine resmetirom (Rezdiffra) to treat adult patients with metabolic dysfunction-associated steatohepatitis. ...
Posted by Michael Wonder on 04 Jun 2026
European Commission approves Amgen's Imdylltra for the treatment of extensive-stage small cell lung cancer
1 June 2026 - Amgen today announced that the European Commission has granted marketing authorisation for Imdylltra (tarlatamab) as a ...
Posted by Michael Wonder on 04 Jun 2026
AbbVie announces European Commission approval of Aquipta (atogepant) for the acute treatment of migraine in adults
2 June 2026 - AbbVie today announced that the European Commission has approved Aquipta (atogepant) for the acute treatment of migraine ...
Posted by Michael Wonder on 04 Jun 2026
Why Canada has generic Ozempic, and the US doesn't
3 June 2026 - Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to help ...
Posted by Michael Wonder on 04 Jun 2026
AstraZeneca pulls critical breast cancer and endometriosis drug Zoladex from shelves
4 June 2026 - A life-saving breast cancer and endometriosis drug will be pulled from Australian shelves by a major ...
Posted by Michael Wonder on 04 Jun 2026
Verastem Oncology announces US FDA fast track designation for VS-7375, an oral and potential best in class investigational KRAS G12D (ON/OFF) inhibitor for the treatment of KRAS G12D mutated locally advanced or metastatic non-small cell lung cancer
3 June 2026 - Verastem Oncology today announced that the US FDA has granted hast track designation to VS-7375, an oral ...
Posted by Michael Wonder on 03 Jun 2026
Terremoto Biosciences granted FDA fast track designation for TER-2013, an AKT1 selective small molecule inhibitor for breast cancer
3 June 2026 - Terremoto Biosciences today announced that the US FDA granted fast track designation for TER-2013, the Company’s lead ...
Posted by Michael Wonder on 03 Jun 2026
Cingulate receives complete response letter from FDA for CTx-1301
2 June 2026 - Cingulate today announced that the US FDA has issued a complete response letter for its new ...
Posted by Michael Wonder on 03 Jun 2026
FDA approves more orphan drugs with specific cancer, paediatric indications over EMA
2 June 2026 - The US FDA is more likely to approve drugs with an orphan designation that were indicated ...
Posted by Michael Wonder on 03 Jun 2026
Global tensions with US President Donald Trump could threaten affordable medicines in Australia
2 June 2026 - Australia’s access to affordable medicines could be under threat from global tensions, with one woman forced to ...
Posted by Michael Wonder on 03 Jun 2026
Cheaper medicines for people fighting leukaemia and migraines
3 June 2026 - The Albanese Government is continuing to deliver cheaper medicines with Australians with types of leukaemia and ...
Posted by Michael Wonder on 03 Jun 2026
TearSolutions receives FDA orphan drug and fast track designations for Lacripep in neurotrophic keratitis
2 June 2026 - TearSolutions today announced receiving FDA orphan drug and fast track designations for Lacripep in neurotrophic keratitis. ...